FDA Approval Expands Access to Factor Xa Inhibitor Antidote Andexxa - Monthly Prescribing Reference

FDA Approval Expands Access to Factor Xa Inhibitor Antidote Andexxa  Monthly Prescribing Reference

Portola announced that the Food and Drug Administration (FDA) has approved the Prior Approval Supplement (PAS) for its second generation Andexxa ...